Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Hengsheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Nanjing, China, specializing in the research, development, and manufacturing of chemical drug preparations. Established in 1995, the company has built a robust portfolio of products targeting major therapeutic areas such as cardiovascular health, gastroenterology, and infectious diseases. Its manufacturing facilities are fully GMP-certified, supporting the production of various dosage forms including tablets, capsules, and small-volume injections. The company is a significant player in the Chinese generic drug market, providing essential medications like amlodipine and omeprazole to the domestic healthcare system. Nanjing Hengsheng is recognized as a high-tech enterprise in Jiangsu Province, committed to maintaining high quality standards and expanding its clinical reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Hengsheng Pharmaceutical.